Author

A. Quintana

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:clustering· 1 Research Focus:development & morphogenesis· 1 Organism:Drosophila· 1

Frequent Co-Authors

A. Derfoul· 1 shared A. E. Gaspar-Maia· 1 shared A. Hinton· 1 shared A. Karsan· 1 shared A. L. Mammen· 1 shared A. Marshall· 1 shared A. Matas-Garcia· 1 shared A. Rajan· 1 shared

Activity by Year

2022-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Derfoul

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor-induced myositis

I. Pinal-Fernandez, A. Quintana, J. Milisenda, M. Casal-Dominguez, S. Munoz-Braceras, A. Derfoul, J. Torres-Ruiz, K. Pak, S. Del Orso, F. Naz, G. Gutierrez-Cruz, M. Milone, S. Shelly, Y. Duque-Jaimez, E. Tobias-Baraja, , A. L. Mammen

This study identifies three distinct transcriptomic subsets of immune checkpoint inhibitor-induced myositis using bulk and single-nuclei RNA sequencing.

bioRxiv · Dec 12, 2022Immunology

Targeting BET Proteins downregulates miR-33a to promote synergy with PIM inhibitors in CMML

C. Letson, M. E. Balasis, H. Newman, M. Binder, A. Vedder, F. Kinose, M. Ball, T. Kruer, A. Quintana, T. L. Lasho, C. M. Finke, L. L. Almada, J. M. Grants, G. Zhang, M. E. Fernandez-Zapico, , E. Padron

This study identifies PIM inhibitors as synergistic with BET inhibitors in myeloid leukemia, showing miR-33a downregulation drives PIM1 upregulation and GM-CSF hypersensitivity as a biomarker for combination therapy.

bioRxiv · Nov 1, 2022Cancer Biology

ATF4 Dependent Increase in Mitochondrial-Endoplasmic Reticulum Tethering Following OPA1 Deletion in Skeletal Muscle

A. Hinton, P. Katti, M. Mungai, D. Hall, O. Koval, J. Shao, Z. Vue, E. G. Lopez, R. Rostami, K. Neikirk, J. Ponce, J. Streeter, B. Schickling, S. Bacevac, C. Grueter, , E. D. Abel

This study shows that OPA1 deficiency in skeletal muscle increases MERC formation via ATF4, affecting calcium exchange and mitochondrial-ER tethering.

bioRxiv · Sep 12, 2022Biophysics